Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen
Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen
傑富瑞將羅董藥品的評級從買入下調至表現不佳，將目標價格從3900日元調整至2450日元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間